Utility of anti-factor Xa levels in pregnant women receiving low molecular weight heparin prophylaxis

被引：0
|
作者：
Allred, Emily [1 ]
Quinn, Kristen [1 ]
Thorsen, Julia [1 ]
Pradarelli, Jason [2 ]
Baker, Lisa [3 ]
Szabo, Aniko [1 ]
Zhao, Shi [1 ]
Wassenaar, Timothy [3 ]
Kuhlman, Randall [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Univ Michigan, Sch Med, Ann Arbor, MI USA
[3] Waukesha Mem Hosp, Waukesha, WI USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2013年 / 208卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2012.10.831
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S280 / S280
页数：1
相关论文
共 50 条
  • [21] Correlation between the low molecular weight heparin prophylactic dose and the plasma levels of anti Xa activity in pregnant women
    Mitic, G.
    Jurisic, Dj.
    Scekic, M.
    Spasic, D.
    Petkovic, M.
    Jakovljevic, B.
    Jelicic, Z. D.
    [J]. THROMBOSIS RESEARCH, 2009, 123 : S143 - S143
  • [22] Anti-factor Xa assay: An effective method to determine the appropriate dose of heparin in pregnant women
    Vineeta, Sharma
    Prakash, Choudbry Ved
    Renu, Saxena
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2008, 14 (01) : 118 - 119
  • [23] Enoxaparin Dose Requirements to Achieve Therapeutic Low-molecular-weight Heparin Anti-factor Xa Levels in Infants and Young Children
    Wysocki, Emma L.
    Kuhn, Alexis
    Steinbrenner, Jenny
    Tyrrell, Laura
    Abdel-Rasoul, Mahmoud
    Dunn, Amy
    Cloyd, Colleen
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (07) : E946 - E950
  • [24] Monitoring of Anti-Xa in Pregnant Patients with Mechanical Prosthetic Valves Receiving Low Molecular Weight Heparin: Peak or Trough Levels?
    John, Fan
    Goland, Sorel
    Khatri, Nudrat
    Elkayam, Uri
    [J]. CIRCULATION, 2010, 122 (21)
  • [25] Validation of a weight based heparin nomogram that utilizes anti-factor Xa levels for monitoring.
    Huh, Jin-Hyeun
    Leong, Derek
    Lau, Maxine
    Gavrilovic, Maja
    [J]. BLOOD, 2006, 108 (11) : 108B - 108B
  • [26] The adequacy of low molecular weight heparin prophylaxis and treatment in pregnant women
    Carroll, A.
    Nash, M. J.
    Tower, C.
    Hay, C. R. M.
    Byrd, L.
    Thachil, J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 32 - 32
  • [27] Low molecular weight heparin for venous thromboembolism prophylaxis in general Intensive Care Unit patients: an anti-factor Xa level-based approach
    Zohar, Nitzan
    Ellis, Martin H.
    Dichtwald, Sara
    Meyer, Avraham
    Zohar, Edna
    Ifrach, Nisim
    [J]. MINERVA ANESTESIOLOGICA, 2023, 89 (05) : 425 - 433
  • [28] ANTI-FACTOR XA LEVELS IN PICU PATIENTS ON ENOXAPARIN FOR VENOTHROMBOEMBOLISM PROPHYLAXIS
    Marshall, Amanda
    Malone, Matthew
    Yee, Addison
    [J]. CRITICAL CARE MEDICINE, 2019, 47
  • [29] Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis
    Pannucci, Christopher J.
    Prazak, Ann Marie
    Scheefer, Melody
    [J]. AMERICAN JOURNAL OF SURGERY, 2017, 213 (06): : 1143 - 1152
  • [30] Monitoring of Anti-Xa in Pregnant Patients With Mechanical Prosthetic Valves Receiving Low-Molecular-Weight Heparin: Peak or Trough Levels?
    Goland, Sorel
    Schwartzenberg, Shmuel
    Fan, John
    Kozak, Natasha
    Khatri, Nudrat
    Elkayam, Uri
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (05) : 451 - 456
12345